Chat with us, powered by LiveChat

BioWavePro PENS

BioWave : Biowave Pens and Machines

Call To Speak To A Specialist

BioWavePro PENS

The BiowavePRO is an FDA, 510(k) cleared percutaneous electrical nerve stimulator (PENS)

PENS is a Diagnostic Modality used in the continuum of care process to determine next steps; confirm or rule out the potential therapeutic usefulness of a permanent electrical nerve stimulator for patients suffering from chronic pain

  • Used to confirm or rule out the potential therapeutic usefulness of an implantable electrical nerve stimulator.

Utilizes patented deep tissue signal technology using percutaneous needle electrode that provides direct conductive pathway through skin into deep tissue

Sterile, single-use needle electrodes – deliver 2 continuously high freq A/C signals and these sine waves create a low frequency signal in the form of an active electrical field.

Contact with polarized tissue: C-Fiber, A Delta Fibers and Muscle tissue

  • 75% patient response rate
  • 75% reduction in VAS Pain scores
  • Significant increase in ROM, Reduction in stiffness and muscle spasm
  • 30-minute treatment provides up to 72 hours of continued pain relief and functional improvement

Biowave has been shown to reduce the need for morphine, narcotics, and other pain medications resulting in better quality of life scores.

For equipment specifications, purchasing and financing options Call : 954-451-6395

Description

Patient Selection:

  • The patients whom you select for the procedure should present with conditions / diagnoses that are compatible from a continuum of care standpoint; the goal is to assess the patient’s suitability for the therapeutic usefulness of ongoing treatment via a permanent stimulator
  • It is important that the physician’s documentation entails all prior conventional & conservative interventions.
  • TENS, P.T., and medications (e.g., NSAIDS, Narcotics, and Opioids) are all examples of interventions that would be expected to have been tried and failed prior to proceeding with the use of PENS for the treatment of chronic pain.

Treatment:

  • 6-8 treatments within 30 days (2 x wk x 3-4 wks)
  • 30 minutes per treatment
  • After completing 6-8 treatments the patient’s VAS score should be documented

Average Reimbursement

Medicare (per patient) = $1,800 ROI

1 Bundle = 1 patient for 6 treatments

[$300 per procedure + $200 provided by Medicare (Pass through) – $200 set of electrodes]

$300.00 per procedure x 6 recommended procedures = $1800.00

Commercial (per patient) = $2,700 ROI

1 Bundle = 1 patient for 6 treatments

[$650 per procedure – $200 per set of electrodes]

$450.00 per procedure x 6 recommended procedures = $2700.00

For equipment specifications, purchasing and financing options Call : 954-451-6395

Treatment Note Example
Rush University Medical Center Clinical Study
pt selection tool for FLA (002)
EOB scan
BiowavePWP
Aetna EOBs PENS 2015
Biowave User Manual

Back to top